NASDAQ:FCSC Fibrocell Science (FCSC) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free FCSC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.00▼$3.0050-Day Range$3.00▼$3.0052-Week Range$1.45▼$3.28VolumeN/AAverage Volume78,673 shsMarket Capitalization$29.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Fibrocell Science alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Fibrocell Science Stock (NASDAQ:FCSC)Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin and connective tissues in the United States. The company's gene therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, a gene therapy for localized scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions. It has collaboration agreement with Intrexon Corporation for the development of FCX-007, FCX-013, and products for the treatment of chronic inflammation and degenerative diseases of human joints. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was incorporated in 1992 and is based in Exton, Pennsylvania.Read More Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here FCSC Stock News HeadlinesFebruary 20, 2024 | forbes.comBest Data Science Bootcamps Online In 2024February 6, 2024 | dailymail.co.ukScience & Tech NewsApril 26, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…September 16, 2023 | usnews.comWhat You Need to Know About Becoming a Computer Science MajorApril 7, 2023 | marketwatch.comEpidermolysis Bullosa Therapeutics Market Factual Overview Research Report 2023-2030January 13, 2023 | forbes.comOramed PharmaceuticalsDecember 27, 2022 | thestreet.comFibrocell Science (FCSC) Stock Spikes Following Rare Pediatric Disease Treatment DesignationSee More Headlines Receive FCSC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fibrocell Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2019Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:FCSC CUSIPN/A CIK357097 Webfibrocell.com Phone484-713-6000FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.45) Trailing P/E RatioN/A Forward P/E Ratio30.00 P/E GrowthN/ANet Income$-10,280,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity23.10% Return on Assets10.56% Debt Debt-to-Equity Ratio0.47 Current Ratio5.09 Quick Ratio5.09 Sales & Book Value Annual Sales$350,000.00 Price / Sales83.66 Cash FlowN/A Price / Cash FlowN/A Book Value$0.98 per share Price / Book3.06Miscellaneous Outstanding Shares9,760,000Free FloatN/AMarket Cap$29.28 million OptionableOptionable Beta1.67 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. John Michael Maslowski (Age 44)Pres, CEO & Director Mr. Sean D. Buckley (Age 37)VP of Bus. Admin. & Corp. Sec. Mr. Robert G. PartridgeVP of Global Marketing, Communications and Investor RelationsMs. Michele Mchugh-MazzattaVP of SalesDr. Pierre CompteManaging Director of SwitzerlandKey CompetitorsAprea TherapeuticsNASDAQ:APRELexaria BioscienceNASDAQ:LEXXSpruce BiosciencesNASDAQ:SPRBDaré BioscienceNASDAQ:DARENRx PharmaceuticalsNASDAQ:NRXPView All Competitors FCSC Stock Analysis - Frequently Asked Questions How were Fibrocell Science's earnings last quarter? Fibrocell Science Inc (NASDAQ:FCSC) announced its earnings results on Wednesday, August, 14th. The company reported $1.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.18) by $1.30. The company had revenue of $21.79 million for the quarter. When did Fibrocell Science's stock split? Fibrocell Science's stock reverse split on Friday, May 25th 2018. The 1-5 reverse split was announced on Thursday, May 24th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 24th 2018. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. What other stocks do shareholders of Fibrocell Science own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fibrocell Science investors own include The Carlyle Group (CG), Celldex Therapeutics (CLDX), Neos Therapeutics (NEOS), Amarin (AMRN), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Neurotrope (NTRP), Verastem (VSTM), Synergy Pharmaceuticals (SGYP) and Agile Therapeutics (AGRX). This page (NASDAQ:FCSC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fibrocell Science Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.